Prevalence and predictors of cancer among diabetic individuals in the United States

The increasing prevalence of diabetes in the United States poses a significant public health issue due to its link with a higher cancer risk. This study utilized data from the 2022 Behavioral Risk Factor Surveillance System (BRFSS) to ascertain the prevalence of cancer among diabetics and identify key factors affecting this risk. These insights are crucial for crafting effective health interventions to lower the cancer burden. Data from the 2022 BRFSS were analyzed to explore cancer incidence among diabetics in the U.S. With a sample size of 62,689 diabetic individuals, descriptive analyses and survey logistic regression models were used to determine the prevalence and predictors of cancer. The data were recoded based on existing literature, and both unadjusted and adjusted odds ratios were calculated. The study found a 13.48% cancer prevalence among diabetic patients. Multivariate logistic regression identified several significant cancer predictors. Age was a major factor, with older adults having higher cancer odds (AOR = 4.14; CI 2.95–5.82). Racial disparities were notable, with Non-Hispanic blacks (AOR = 0.56; CI 0.47–0.67) facing higher odds than Non-Hispanic whites. Female gender were also linked to increased cancer odds (AOR= 1.15; CI 1.38–2.72). Individual without depressive disorder have reduced odds of cancer (AOR = 0.81; CI 0.71–0.92). Physical activity was not a statistically significant predictor of cancer among diabetics when adjusting for other variables. The study confirmed a higher prevalence of cancer among diabetics compared to the general population, highlighting the need for integrated healthcare strategies prioritizing regular cancer screening and addressing modifiable risk factors like socioeconomic disparities and mental health. These findings offer a solid foundation for public health interventions aimed at reducing the cancer burden in diabetic populations by targeting modifiable behaviors and social determinants of health.

Authors

Institutions

Publication Details

Journal
Discover Epidemics
Published
2024-12-19
DOI
https://doi.org/10.1007/s44203-024-00002-7
Citations
3
Primary Topic
Metabolism, Diabetes, and Cancer
Type
article
Field-Weighted Citation Impact
0.70
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prevalence and predictors of cancer among diabetic individuals in the United States

Onyeka Chukwudalu Ekwebene, Emmanuel Angmorteh Mensah, Gabriel Chidera Edeh, Chioma Favour Ekwebene et al.
3 citations
Discover Epidemics
Metabolism, Diabetes, and Cancer
0.70
article

Prevalence and predictors of cancer among diabetic individuals in the United States

Onyeka Chukwudalu Ekwebene, Emmanuel Angmorteh Mensah, Gabriel Chidera Edeh, Chioma Favour Ekwebene, George Uchenna Eleje, Olajide J Olagunju, M.M. Ahmed Suleiman
article en
3 citations

Abstract

The increasing prevalence of diabetes in the United States poses a significant public health issue due to its link with a higher cancer risk. This study utilized data from the 2022 Behavioral Risk Factor Surveillance System (BRFSS) to ascertain the prevalence of cancer among diabetics and identify key factors affecting this risk. These insights are crucial for crafting effective health interventions to lower the cancer burden. Data from the 2022 BRFSS were analyzed to explore cancer incidence among diabetics in the U.S. With a sample size of 62,689 diabetic individuals, descriptive analyses and survey logistic regression models were used to determine the prevalence and predictors of cancer. The data were recoded based on existing literature, and both unadjusted and adjusted odds ratios were calculated. The study found a 13.48% cancer prevalence among diabetic patients. Multivariate logistic regression identified several significant cancer predictors. Age was a major factor, with older adults having higher cancer odds (AOR = 4.14; CI 2.95–5.82). Racial disparities were notable, with Non-Hispanic blacks (AOR = 0.56; CI 0.47–0.67) facing higher odds than Non-Hispanic whites. Female gender were also linked to increased cancer odds (AOR= 1.15; CI 1.38–2.72). Individual without depressive disorder have reduced odds of cancer (AOR = 0.81; CI 0.71–0.92). Physical activity was not a statistically significant predictor of cancer among diabetics when adjusting for other variables. The study confirmed a higher prevalence of cancer among diabetics compared to the general population, highlighting the need for integrated healthcare strategies prioritizing regular cancer screening and addressing modifiable risk factors like socioeconomic disparities and mental health. These findings offer a solid foundation for public health interventions aimed at reducing the cancer burden in diabetic populations by targeting modifiable behaviors and social determinants of health.

Discover EpidemicsVol. 1(1)
East Tennessee State University (US), Nnamdi Azikiwe University (NG), Case Western Reserve University (US)
Good health and well-being
Openalex Percentile: Top 28%
Metabolism, Diabetes, and Cancer
0.70
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.